PSIL ETF (ADVISORSHARES PSYCHEDELICS ETF) is managed by Advisor Shares with $20.1M in net assets. PSIL expense ratio is 1.00%, holding 29 positions across sectors including Health Care, Unknown, Other. Inception date: 2021-09-15.

PSIL performance shows a YTD return of -0.07%. The 1-year return is 48.28%. PSIL dividend yield stands at 11.05%, paid quarterly.

PSIL top holdings include Atai Life Sciences BV (12.1%), Compass Pathways Plc Adr (8.6%), Relmada Therapeutics Inc Common Stock (8.3%), Supernus Pharmaceuticals Inc (7.6%), Mind Medicine Mindmed Inc (7.5%). View all PSIL holdings, sector breakdown, or dividend history.

PSIL can be compared against other funds using the overlap calculator or side-by-side comparison tool. PSIL alternatives are available via the screener, along with tax-loss harvesting opportunities.